{"entity":{"type":"insider","cik":"0001734339","url":"/insider/0001734339","json_url":"/insider/0001734339.json","name":"Barclay Alec","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2019-09-13","last":"2022-04-11","span_basis":"filed_date"},"name_variants":[{"name":"Barclay Alec","source":"filing","n_filings":5,"first_seen":"2019-09-13","last_seen":"2022-04-11"}],"transactions":[{"id":6200114,"accession":"0000899243-22-014418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014418","line_url":"/filing/0000899243-22-014418#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001734339","owner_name":"Barclay Alec","owner_url":"/insider/0001734339","role":"Officer (Chief Operations Officer)","officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12951.88,"shares_display":"12,951.88","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":6475.94,"total_display":"6,475.94","shares_owned_after":181944.88,"shares_owned_after_display":"181,944.88","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-11","scope":"insider"},{"id":5087665,"accession":"0000899243-21-012548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-012548","line_url":"/filing/0000899243-21-012548#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001734339","owner_name":"Barclay Alec","owner_url":"/insider/0001734339","role":"Officer (Chief Operations Officer)","officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12494.0,"shares_display":"12,494","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":23238.84,"total_display":"23,238.84","shares_owned_after":74420.0,"shares_owned_after_display":"74,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-18","scope":"insider"},{"id":4350430,"accession":"0000899243-21-007771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007771","line_url":"/filing/0000899243-21-007771#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001734339","owner_name":"Barclay Alec","owner_url":"/insider/0001734339","role":"Officer (Chief Operations Officer)","officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7280.0,"shares_display":"7,280","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":14996.8,"total_display":"14,996.80","shares_owned_after":65247.0,"shares_owned_after_display":"65,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-23","scope":"insider"},{"id":2418023,"accession":"0000899243-20-005808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005808","line_url":"/filing/0000899243-20-005808#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001734339","owner_name":"Barclay Alec","owner_url":"/insider/0001734339","role":"Officer (SVP, Operations)","officer_title":"SVP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5808.0,"shares_display":"5,808","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":4762.56,"total_display":"4,762.56","shares_owned_after":46294.0,"shares_owned_after_display":"46,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-25","scope":"insider"},{"id":8761811,"accession":"0000899243-19-023537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-023537","line_url":"/filing/0000899243-19-023537#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001734339","owner_name":"Barclay Alec","owner_url":"/insider/0001734339","role":"Officer (SVP, Operations)","officer_title":"SVP, Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4210.0,"shares_display":"4,210","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":12293.2,"total_display":"12,293.20","shares_owned_after":42102.0,"shares_owned_after_display":"42,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492674","name":"T2 Biosystems, Inc.","url":"/issuer/0001492674","role":"Officer (Chief Operations Officer)","n_filings":5,"first_seen":"2019-09-13","last_seen":"2022-04-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001734339","retrieved_at":"2026-08-21T00:56:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}